Pregnancy is known as a period associated with important physiological and psychological changes in women's lives. There is moderately sufficient evidence in the literature to recommend supplementing prenatal physical activity for maternal health benefits. It has been reported that physical exercise by pregnant women in the absence of obstetric contraindications will not pose a risk to the health of the mother and fetus. In the literature, there are no studies examining the effects of reformer pilates on pain, functional capacity, lumbopelvic stabilization, diastasis recti abdominis, abdominal muscle thickness, respiratory functions, pelvic floor dysfunction, urinary incontinence, sexual function, and venous insufficiency in pregnant women. Therefore, this study aimed to investigate the effects of reformer pilates on pain, functional capacity, lumbopelvic stabilization, diastasis recti abdominis, abdominal muscle thickness, respiratory functions, pelvic floor dysfunction, urinary incontinence, sexual function, and venous insufficiency in pregnant women.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Thickness measurement of the rectus abdominis muscle
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
Thickness measurement of the transversus abdominis muscle
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
Thickness measurement of the external oblique abdominal muscle
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
Thickness measurement of the internal oblique abdominal muscle
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
The forced vital capacity (FVC) value
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
The forced expiratory volume in the first second (FEV1) value
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
The forced expiratory volume in the first second (FEV1)/the forced vital capacity (FVC) (FEV1/FVC) value
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
The peak expiratory flow (PEF) value
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)
Pelvic Floor Dysfunction Assessment
Timeframe: First evaluation (baseline) and final evaluation (6 weeks after first evaluation)